Literature DB >> 24091848

In vitro generation of mature, naive antigen-specific CD8(+) T cells with a single T-cell receptor by agonist selection.

S Snauwaert1, G Verstichel1, S Bonte1, G Goetgeluk1, S Vanhee1, Y Van Caeneghem1, K De Mulder1, C Heirman2, H Stauss3, M H M Heemskerk4, T Taghon1, G Leclercq1, J Plum1, A W Langerak5, K Thielemans2, T Kerre1, B Vandekerckhove1.   

Abstract

Peripheral blood T cells transduced with a tumor-specific T-cell receptor (TCR) face problems of auto-reactivity and lack of efficacy caused by cross-pairing of exogenous and endogenous TCR chains, as well as short term in vivo survival due to activation and growth factor-induced differentiation. We here studied an alternative strategy for the efficient generation of naive CD8(+) T cells with a single TCR. TCR-transduced human postnatal thymus-derived and adult mobilized blood-derived hematopoietic progenitor cells (HPCs) were differentiated to CD4(+)CD8(+) double-positive T cells using OP9-Delta-like 1 (OP9-DL1) cultures. Addition of the agonist peptide induced double positive cells to cross-present the peptide, leading, in the absence of co-stimulation, to cell cycle arrest and differentiation into mature CD8(+) T cells. Comprehensive phenotypic, molecular and functional analysis revealed the generation of naive and resting CD8(+) T cells through a process similar to thymic positive selection. These mature T cells show a near complete inhibition of endogenous TCRA and TCRB rearrangements and express high levels of the introduced multimer-reactive TCR. Upon activation, specific cytokine production and efficient killing of tumor cells were induced. Using this strategy, large numbers of high-avidity tumor-specific naive T cells can be generated from readily available HPCs without TCR chain cross-pairing.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091848     DOI: 10.1038/leu.2013.285

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  44 in total

1.  Human thymocytes become lineage committed at an early postselection CD69+ stage, before the onset of functional maturation.

Authors:  D Vanhecke; B Verhasselt; M De Smedt; G Leclercq; J Plum; B Vandekerckhove
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

2.  Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation.

Authors:  Toshinobu Nishimura; Shin Kaneko; Ai Kawana-Tachikawa; Yoko Tajima; Haruo Goto; Dayong Zhu; Kaori Nakayama-Hosoya; Shoichi Iriguchi; Yasushi Uemura; Takafumi Shimizu; Naoya Takayama; Daisuke Yamada; Ken Nishimura; Manami Ohtaka; Nobukazu Watanabe; Satoshi Takahashi; Aikichi Iwamoto; Haruhiko Koseki; Mahito Nakanishi; Koji Eto; Hiromitsu Nakauchi
Journal:  Cell Stem Cell       Date:  2013-01-03       Impact factor: 24.633

3.  Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

Authors:  Luca Gattinoni; Christopher A Klebanoff; Douglas C Palmer; Claudia Wrzesinski; Keith Kerstann; Zhiya Yu; Steven E Finkelstein; Marc R Theoret; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

4.  Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.

Authors:  Sachiko Okamoto; Junichi Mineno; Hiroaki Ikeda; Hiroshi Fujiwara; Masaki Yasukawa; Hiroshi Shiku; Ikunoshin Kato
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

Review 5.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 6.  Wilms tumor gene (WT1) expression as a panleukemic marker.

Authors:  Hans D Menssen; Jan M Siehl; Eckhard Thiel
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 7.  Adoptive T cell therapy for cancer in the clinic.

Authors:  Carl H June
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

8.  T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse.

Authors:  Amy E Moran; Keli L Holzapfel; Yan Xing; Nicole R Cunningham; Jonathan S Maltzman; Jennifer Punt; Kristin A Hogquist
Journal:  J Exp Med       Date:  2011-05-23       Impact factor: 14.307

9.  Downregulation of CD1 marks acquisition of functional maturation of human thymocytes and defines a control point in late stages of human T cell development.

Authors:  P Res; B Blom; T Hori; K Weijer; H Spits
Journal:  J Exp Med       Date:  1997-01-06       Impact factor: 14.307

10.  Reprogramming of virus-specific T cells into leukemia-reactive T cells using T cell receptor gene transfer.

Authors:  Mirjam H M Heemskerk; Manja Hoogeboom; Renate Hagedoorn; Michel G D Kester; Roel Willemze; J H Frederik Falkenburg
Journal:  J Exp Med       Date:  2004-03-29       Impact factor: 14.307

View more
  13 in total

Review 1.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 2.  Applications of molecular engineering in T-cell-based immunotherapies.

Authors:  David A McBride; Matthew D Kerr; Shinya L Wai; Nisarg J Shah
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-04-10

3.  Generation of Tumor Antigen-Specific iPSC-Derived Thymic Emigrants Using a 3D Thymic Culture System.

Authors:  Raul Vizcardo; Nicholas D Klemen; S M Rafiqul Islam; Devikala Gurusamy; Naritaka Tamaoki; Daisuke Yamada; Haruhiko Koseki; Benjamin L Kidder; Zhiya Yu; Li Jia; Amanda N Henning; Meghan L Good; Marta Bosch-Marce; Takuya Maeda; Chengyu Liu; Zied Abdullaev; Svetlana Pack; Douglas C Palmer; David F Stroncek; Fumito Ito; Francis A Flomerfelt; Michael J Kruhlak; Nicholas P Restifo
Journal:  Cell Rep       Date:  2018-03-20       Impact factor: 9.423

4.  The checkpoint for agonist selection precedes conventional selection in human thymus.

Authors:  Greet Verstichel; David Vermijlen; Liesbet Martens; Glenn Goetgeluk; Margreet Brouwer; Nicolas Thiault; Yasmine Van Caeneghem; Stijn De Munter; Karin Weening; Sarah Bonte; Georges Leclercq; Tom Taghon; Tessa Kerre; Yvan Saeys; Jo Van Dorpe; Hilde Cheroutre; Bart Vandekerckhove
Journal:  Sci Immunol       Date:  2017-02-24

5.  Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.

Authors:  Juwita Hübner; Shahabuddin S Hoseini; Julia D Suerth; Dirk Hoffmann; Marcel Maluski; Jessica Herbst; Holger Maul; Arnab Ghosh; Britta Eiz-Vesper; Qinggong Yuan; Michael Ott; Michael Heuser; Axel Schambach; Martin G Sauer
Journal:  Mol Ther       Date:  2016-05-03       Impact factor: 11.454

6.  Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.

Authors:  Marcel Maluski; Arnab Ghosh; Jessica Herbst; Vanessa Scholl; Rolf Baumann; Jochen Huehn; Robert Geffers; Johann Meyer; Holger Maul; Britta Eiz-Vesper; Andreas Krueger; Axel Schambach; Marcel Rm van den Brink; Martin G Sauer
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

7.  Ginsenoside compound K suppresses the abnormal activation of T lymphocytes in mice with collagen-induced arthritis.

Authors:  Kang-kang Liu; Qing-tong Wang; Si-min Yang; Jing-yu Chen; Hua-xun Wu; Wei Wei
Journal:  Acta Pharmacol Sin       Date:  2014-04-14       Impact factor: 6.150

8.  Generation of mature T cells from human hematopoietic stem and progenitor cells in artificial thymic organoids.

Authors:  Christopher S Seet; Chongbin He; Michael T Bethune; Suwen Li; Brent Chick; Eric H Gschweng; Yuhua Zhu; Kenneth Kim; Donald B Kohn; David Baltimore; Gay M Crooks; Amélie Montel-Hagen
Journal:  Nat Methods       Date:  2017-04-03       Impact factor: 28.547

9.  Antigen receptor-redirected T cells derived from hematopoietic precursor cells lack expression of the endogenous TCR/CD3 receptor and exhibit specific antitumor capacities.

Authors:  Yasmine Van Caeneghem; Stijn De Munter; Paola Tieppo; Glenn Goetgeluk; Karin Weening; Greet Verstichel; Sarah Bonte; Tom Taghon; Georges Leclercq; Tessa Kerre; Reno Debets; David Vermijlen; Hinrich Abken; Bart Vandekerckhove
Journal:  Oncoimmunology       Date:  2017-01-19       Impact factor: 8.110

10.  T-cells with a single tumor antigen-specific T-cell receptor can be generated in vitro from clinically relevant stem cell sources.

Authors:  Sarah Bonte; Stijn De Munter; Glenn Goetgeluk; Joline Ingels; Melissa Pille; Lore Billiet; Tom Taghon; Georges Leclercq; Bart Vandekerckhove; Tessa Kerre
Journal:  Oncoimmunology       Date:  2020-02-17       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.